COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,051 Articles (22,627 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 2600: Articles 25991-26000  | Next

The arrival and spread of SARS-CoV2 in Colombia
Ramirez, J. D., Florez, C., Munoz, M., Hernandez, C., Castillo, A., Gomez, S., Rico, A., Pardo, L., Barros, E. C., Castaneda, S., Ballesteros, N., Martinez, D., Vega, L., Jaimes, J., Cruz-Saavedra, L., Patino, L. H., Teheran, A., Gonzalez-Reiche, A., Hernandez, M., Sordillo, E., Simon, V., van Bakel, H., Paniz-Mondolfi, A.
10.1101/2020.06.11.20125799 — Posted: 2020-06-12
Jinhua Qinggan granule, a Chinese herbal medicine against COVID-19, induces rapid changes in the plasma levels of IL-6 and IFN-γ
Kageyama, Y., Aida, K., Kawauchi, K., Morimoto, M., Ebisui, T., Akiyama, T., Nakamura, T.
10.1101/2020.06.08.20124453 — Posted: 2020-06-12
Estimated Average Probabilities of COVID-19 Infection, Hospitalization, and Death From Community Contact in the United States
Bhatia, R., Klausner, J.
10.1101/2020.06.06.20124446 — Posted: 2020-06-12 Discussion: Onsite
Disproportionate COVID-19 Related Mortality Amongst African Americans in Four Southern States in the United States
Betson, D. N., Maitra, D. A.
10.1101/2020.06.08.20124297 — Posted: 2020-06-12
The effectiveness of social bubbles as part of a Covid-19 lockdown exit strategy, a modelling study
Leng, T., Whie, C., Hilton, J., Kucharski, A. J., Pellis, L. J., Stage, H., Davies, N. G., Flasche, S. G., Keeling, M. J.
10.1101/2020.06.05.20123448 — Posted: 2020-06-12
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Herroelen, P. H., Martens, G. A., De Smet, D., Swaerts, K., Decavele, A.-S.
10.1101/2020.06.09.20124719 — Posted: 2020-06-12
Predictors of household food insecurity in the United States during the COVID-19 pandemic
Lauren, B. N., Silver, E. R., Faye, A. S., Woo Baidal, J. A., Ozanne, E. M., Hur, C.
10.1101/2020.06.10.20122275 — Posted: 2020-06-12
Clinical outcomes of SARS-CoV-2 pandemic in long-term care facilities for people with epilepsy: observational study
Balestrini, S., Koepp, M. J., Gandhi, S., Rickman, H., Shin, G. Y., Houlihan, C., Anders-Cannon, J., Silvennoinen, K., Xiao, F., Zagaglia, S., Hudgell, K., Ziomek, M., Haimes, P., Sampson, A., Parker, A., Cross, J. H., Pardington, R., Nastouli, E., Swanton, C., Sander, J. W., Sisodiya, S.
10.1101/2020.06.10.20123281 — Posted: 2020-06-12
An imperfect tool: COVID-19 'test & trace' success relies on minimising the impact of false negatives and continuation of physical distancing.
Davis, E. L., Lucas, T. C. D., Borlase, A., Pollington, T. M., Abbott, S., Ayabina, D., Crellen, T., Hellewell, J., Pi, L., Medley, G. F., Hollingsworth, T. D., Klepac, P.
10.1101/2020.06.09.20124008 — Posted: 2020-06-12
Oscillations in USA COVID-19 Incidence and Mortality Data reflect societal factors
Bergman, A., Sella, Y., Agre, P., Casadevall, A.
10.1101/2020.06.08.20123786 — Posted: 2020-06-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).